Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eon Generic Transdermal Estrogen Patch Under Development With Hexal AG

Executive Summary

Eon Labs is developing a generic transdermal estrogen patch with German partner Hexal AG

You may also be interested in...



Corcept To Test Sluggish IPO Market For Biotechs

Corcept Therapeutics will test the sluggish market for biopharmaceutical initial public offerings with an IPO slated for June 10

Corcept To Test Sluggish IPO Market For Biotechs

Corcept Therapeutics will test the sluggish market for biopharmaceutical initial public offerings with an IPO slated for June 10

Eon's Cyclosporine Capsules Receive Approval As First-Time Neoral Generic

FDA's generic drugs office opened 2000 with the Jan. 13 approval of Eon Labs' cyclosporine softgel capsules as the first generic of Novartis' Neoral capsules, which comprise 96% of the cyclosporine market.

UsernamePublicRestriction

Register

PS039478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel